
WEIGHT: 59 kg
Bust: 38
One HOUR:90$
NIGHT: +40$
Services: Disabled Clients, Sauna / Bath Houses, Role Play & Fantasy, Food Sex, Gangbang / Orgy
Official websites use. Share sensitive information only on official, secure websites. This work is published and licensed by Dove Medical Press Limited. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4. The economic burden of diabetes from a societal perspective is well documented in the cost-of-illness literature.
However, the effect of considering social costs in the results and conclusions of economic evaluations of diabetes-related interventions remains unknown. A systematic review was designed and launched on Medline and the Cost-Effectiveness Analysis Registry from the University of Tufts, from the year until Included studies had to fulfil the following criteria: i being an original study published in a scientific journal, ii being an economic evaluation of an intervention on diabetes, iii including social costs, iv being written in English, v using quality-adjusted life years as outcome, and vi separating the results according to the perspective applied.
From the records identified, 47 studies 6. The 47 studies resulted in economic evaluation estimations. When social costs are considered, the results and conclusions of economic evaluations performed in diabetes-related interventions can alter. Wide methodological variations have been observed, which limit the comparability of studies and advocate for the inclusion of a wider perspective via the consideration of social costs in economic evaluations and methodological guidelines relating to their estimation and valuation.
Keywords: diabetes, social costs, informal care, productivity losses, economic evaluation, health technology assessment. Despite the heavy burden of social costs related to diabetes, there is still a lack of evidence about the consequences of excluding them from economic evaluations of interventions targeting people with diabetes.
Our findings showed that, of the records that consisted of a full diabetes-associated economic evaluation, only included social costs However, comparisons should be made with caution, as the different types of diabetes affect completely different profiles, with respect to age, state of health and lifestyle.